North China Pharmaceutical Company Ltd Financials

Market Capitalization CN¥9.26 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	108.00
Forward PE
Price to Sales TTM	CN¥0.95
Price to Book MRQ	CN¥1.73
Enterprise to Revenue	2.09
Enterprise to EBITDA	15.20

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	0.82%
Operating Margin	7.68%
Return on Assets TTM	1.69%
Return on Equity TTM	2.26%

Income Statement

Revenue TTM	CN¥9,705,755,648
Revenue per Share TTM	CN¥6.07
Quarterly Revenue Growth	-15.00%
Gross Profit TTM	CN¥2,970,652,160
EBITDA	CN¥674,198,311
Net Income to Common TTM	CN¥79,380,904
Diluted EPS TTM	CN¥0.05
Quarterly Earnings Growth YoY	2035.10%

Balance Sheet

Total Cash MRQ	CN¥1,721,574,144
Total Cash per Share MRQ	CN¥1.00
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	174.65
Current Ratio MRQ	0.78
Book Value per Share MRQ	CN¥3.13

Cash Flow

Operating Cash Flow TTM	CN¥1,488,937,216
Levered Free Cash Flow TTM	CN¥578,048,448

600812 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,715,730,048
Float Shares	358,947,951
Avg 10 Volume	34,413,729
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	58.20%
% Held by Institutions	5.72%

Stock Price Summary

Beta	1.16
Fifty Two Week Low	CN¥3.83
Fifty Two Week High	CN¥6.22
Fifty Two Week Change	9.63%
Day 50 MA	CN¥5.46
Day 200 MA	CN¥5.01

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.01
Forward Annual Dividend Yield	0.19%
Trailing Annual Dividend Rate	CN¥0.01
Trailing Annual Dividend Yield	0.19%
Payout Ratio	21.28%
Dividend Date
Ex Dividend Date	2024-07-18
Last Split Factor
Last Split Date	2006-08-15